HNF4A and colorectal carcinoma: Abrogating CRC development by (n-3) PUFA may be ascribed to both, (n-3) PUFA efficacy in ameliorating the diabetic phenotype, combined with (n-3) PUFA efficacy in suppressing the expression and transcriptional activities of colonic HNF-4α and β-catenin/Tcf.